Has Medicare Part D Reform Finally Arrived?
For as long as the Medicare Part D prescription drug plan has existed, beneficiaries have struggled with out-of-pocket costs. Now, movement on Capitol Hill suggests this may finally be the year for reform.
Genetic Testing and Counseling Offer Answers for Rare Disease Patients
Genetic testing and counseling can be critical for health care providers and patients to make informed treatment choices – especially when it comes to rare diseases.
State Legislatures Explore How to Measure a Drug’s Value
What is a vaccine, a cure or a life-altering medication worth? As more state legislatures across the country explore this very question, their answers – and their methods – may not sync with their constituents’ values.
Children’s Cardiomyopathy: A Family Affair
One day, when my son Dean was just seven weeks old, his grandma was over for a visit. She held him as we chatted, but I had a hard time following the conversation.
Childhood Obesity Climbs Higher
Childhood obesity – worsened by a year of lockdowns and loosely structured online school – is on the rise.
A New Approach for Treating AFib
A new treatment approach may allow patients to manage AFib more effectively.
How Should Telehealth be Used Post Pandemic?
What role will telehealth play in a post-COVID world? Patients, health care providers and policymakers are discovering that the question is both complex and critical.
Hidden Co-Pay Programs Blindside Patients
Just as states started banning abusive co-pay accumulator programs, insurers have found a work-around that once again could put patients at a disadvantage when it comes to out-of-pocket prescription drug costs.
The Urgent Need to Address Urology Health
The shortage of nursing assistants is having dire consequences for older adults. Millions of patients are going without the support they need to prepare meals, organize medications and run errands. They also may be lacking support to get safely to the bathroom or change undergarments and bedding during times of incontinence.
New Federal Policy Could Limit Non-Opioid Pain Treatments
Treating pain without opioids has become possible for many patients through novel drugs approved by a regulatory process called 505(b)(2). Now, access to these treatments is in jeopardy.
